Christopher M. Booth

13.8k total citations · 4 hit papers
323 papers, 8.7k citations indexed

About

Christopher M. Booth is a scholar working on Oncology, Economics and Econometrics and Surgery. According to data from OpenAlex, Christopher M. Booth has authored 323 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Oncology, 104 papers in Economics and Econometrics and 88 papers in Surgery. Recurrent topics in Christopher M. Booth's work include Economic and Financial Impacts of Cancer (80 papers), Health Systems, Economic Evaluations, Quality of Life (74 papers) and Bladder and Urothelial Cancer Treatments (50 papers). Christopher M. Booth is often cited by papers focused on Economic and Financial Impacts of Cancer (80 papers), Health Systems, Economic Evaluations, Quality of Life (74 papers) and Bladder and Urothelial Cancer Treatments (50 papers). Christopher M. Booth collaborates with scholars based in Canada, United States and United Kingdom. Christopher M. Booth's co-authors include William J. Mackillop, Ian F. Tannock, Safiya Karim, Bishal Gyawali, Sulaiman Nanji, George Tomlinson, Timothy P. Hanna, James Biagi, D. Robert Siemens and Michael J. Raphael and has published in prestigious journals such as Nature, JAMA and Journal of Clinical Oncology.

In The Last Decade

Christopher M. Booth

307 papers receiving 8.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Features and Short-term Outcomes of 144 Patients With SARS in the Greater Toronto Area

2003 1.0k citations Christopher M. Booth profile →
Association Between Time to Initiation of Adjuvant Chemotherapy and Survival in Colorectal Cancer

2011 463 citations Michael J. Raphael, William J. Mackillop et al. profile →
Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence

2014 335 citations Christopher M. Booth et al. profile →
Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic

2020 266 citations Christopher M. Booth et al. profile →

Peers

Countries citing papers authored by Christopher M. Booth

Since Specialization

Citations

This map shows the geographic impact of Christopher M. Booth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher M. Booth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher M. Booth more than expected).

Fields of papers citing papers by Christopher M. Booth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher M. Booth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher M. Booth. The network helps show where Christopher M. Booth may publish in the future.

Co-authorship network of co-authors of Christopher M. Booth

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher M. Booth. A scholar is included among the top collaborators of Christopher M. Booth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher M. Booth. Christopher M. Booth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Patient Preferences on Clinical Decision Making in Multiple Myeloma 2025 ·JCO Oncology Practice ·Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, (unknown), (unknown), (unknown), (unknown), (unknown), Douglas W. Sborov, Amandeep Godara, Brian McClune, Christopher M. Booth, Edward R. Scheffer Cliff	0
2	Novel Systemic Anticancer Treatments and Health Services Use at the End of Life Among Adults With Cancer 2025 ·Journal of Clinical Oncology ·Javaid Iqbal, Rahim Moineddin, Kieran L. Quinn, Christopher M. Booth, Craig C. Earle, Stéphanie Lheureux, Robert C. Grant, Jenny Lau, Lisa W. Le, Peter Tanuseputro, James Downar, Gary Rodin, Hsien Seow, (unknown), Robert Fowler, Breffni Hannon, Monika K. Krzyzanowska, Camilla Zimmermann	1
3	Common Sense Oncology: Equity, Value, and Outcomes That Matter 2024 ·American Society of Clinical Oncology Educational Book ·Brooke E. Wilson, Manju Sengar, Michelle Tregear, Winette T.A. van der Graaf, Nicolò Matteo Luca Battisti, (unknown), Enrique Soto‐Pérez‐de‐Celis, Bishal Gyawali, Christopher M. Booth	4
4	Dietary interventions in cancer: a systematic review of all randomized controlled trials 2024 ·JNCI Journal of the National Cancer Institute ·(unknown), (unknown), (unknown), Edward R. Scheffer Cliff, Christopher M. Booth, (unknown), Muhammad Aziz, Wade Lee‐Smith, Aaron M. Goodman, Rajshekhar Chakraborty, Ghulam Rehman Mohyuddin	9
5	Real-world outcomes associated with use of front-line bevacizumab in ovarian cancer 2023 ·Journal of Cancer Policy ·Josée-Lyne Ethier, Weidong Kong, Helen Mackay, Jacob McGee, Christopher M. Booth	2
6	Financial Toxicity: Unveiling the Burden of Cancer Care on Patients in Rwanda 2023 ·The Oncologist ·Fidel Rubagumya, Brooke E. Wilson, (unknown), Emmanuel Mutabazi, (unknown), (unknown), Mary D. Chamberlin, Wilma M. Hopman, Christopher M. Booth	4
7	More Drugs Versus More Data: The Tug of War on Cancer in Low- and Middle-Income Countries 2023 ·Hematology/Oncology Clinics of North America ·Mary D. Chamberlin, Christopher M. Booth, Gabriel A. Brooks, (unknown), Fidel Rubagumya, Verna Vanderpuye	1
8	Patient Satisfaction With Breast Cancer Care Delivery at the National Cancer Institute of Sri Lanka: Does Language Play a Role? 2023 ·JCO Global Oncology ·(unknown), (unknown), (unknown), (unknown), Christopher M. Booth, Sanjeewa Seneviratne, Sanjeeva Gunasekera, Don Thiwanka Wijeratne	1
9	Global Cancer Drug Development—A Report From the 2022 Accelerating Anticancer Agent Development and Validation Meeting 2023 ·JCO Global Oncology ·Brooke E. Wilson, Richard Sullivan, Richard Peto, (unknown), Christopher M. Booth, Gustavo Werutsky, Cary Adams, Agnès Saint-Raymond, Thomas R. Fleming, H. Kim Lyerly, Julie R. Gralow	6
10	Defining Essential Childhood Cancer Medicines to Inform Prioritization and Access: Results From an International, Cross-Sectional Survey 2022 ·JCO Global Oncology ·Avram Denburg, Adam Fundytus, Muhammad Saghir Khan, Scott C. Howard, Federico Antillón‐Klussmann, Manju Sengar, Dorothy Lombe, Wilma M. Hopman, Matthew Jalink, Bishal Gyawali, Dario Trapani, Felipe Roitberg, Elisabeth G.E. de Vries, Lorenzo Moja, André Ilbawi, Richard Sullivan, Christopher M. Booth	8
11	Colorectal Cancer Treatment Characteristics and Concordance With Guidelines in Sri Lanka: Results From a Hospital-Based Cancer Registry 2022 ·JCO Global Oncology ·Don Thiwanka Wijeratne, (unknown), Christopher M. Booth, Scott Berry, Matthew Jalink, (unknown), Bishal Gyawali, (unknown), Umesh Jayarajah, Sanjeewa Seneviratne	2
12	Time‐to‐event surrogate end‐points in multiple myeloma randomised trials from 2005 to 2019: A surrogacy analysis 2022 ·British Journal of Haematology ·(unknown), (unknown), Douglas W. Sborov, Brian McClune, Vinay Prasad, Alyson Haslam, (unknown), Christopher M. Booth, Samer Al Hadidi, Al‐Ola Abdallah, Aaron M. Goodman, Ghulam Rehman Mohyuddin	10
13	Measuring variation in the quality of systemic anti-cancer therapy delivery across hospitals: A national population-based evaluation 2022 ·European Journal of Cancer ·Jemma M. Boyle, Jan van der Meulen, Angela Kuryba, Thomas E. Cowling, Christopher M. Booth, Nicola Fearnhead, Michael Braun, Kate Walker, Ajay Aggarwal	9
14	Long-Term Mental Health Service Utilization Among Survivors of Testicular Cancer: A Population-Based Cohort Study 2021 ·Journal of Clinical Oncology ·Michael J. Raphael, Sumit Gupta, Xuejiao Wei, Yingwei Peng, Cláudio N. Soares, Philippe L. Bédard, D. Robert Siemens, Andrew Robinson, Christopher M. Booth	20
15	Fibroblast Growth Factor Receptor 3 Mutation as a Prognostic Indicator in Patients with Urothelial Carcinoma: A Systematic Review and Meta-analysis 2020 ·European Urology Open Science ·Sidra Khalid, (unknown), (unknown), Christopher M. Booth, Ignacio Durán, Andrew Robinson, David M. Berman, Martin Smoragiewicz, Eitan Amir, Francisco Vera-Badillo	2
16	PD-L1 expression and clinical outcomes in patients with advanced urothelial carcinoma treated with checkpoint inhibitors: A meta-analysis 2019 ·Cancer Treatment Reviews ·(unknown), Eitan Amir, Markus Kuksis, David Hernández‐Barajas, Laura Rodríguez‐Romo, Christopher M. Booth, Francisco Vera-Badillo	29
17	Delivery of cancer care in Sri Lanka 2018 ·Journal of Cancer Policy ·Sanjeeva Gunasekera, (unknown), (unknown), Christopher M. Booth	21
18	Disease Characteristics, Clinical Management, and Outcomes of Young Patients With Colon Cancer: A Population-based Study 2018 ·Clinical Colorectal Cancer ·Laura Rodríguez, Kelly Brennan, Safiya Karim, Sulaiman Nanji, Sunil V. Patel, Christopher M. Booth	58
19	Testicular Choriocarcinoma Presenting with Massive Hemoptysis and Endobronchial Metastases 2015 ·(unknown), (unknown), (unknown), (unknown), Christopher M. Booth, Richard Gregg	2
20	Adoption of Adjuvant Chemotherapy for Non–Small-Cell Lung Cancer: A Population-Based Outcomes Study 2010 ·Journal of Clinical Oncology ·Christopher M. Booth, Frances A. Shepherd, Yingwei Peng, Gail Darling, Gavin Li, Weidong Kong, William J. Mackillop	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact